Bailey & Glasser LLP



Bailey & Glasser LLP
2001 Main Street, Suite 203
Wheeling, WV 26003

  • T: 304.905.1592
  • F: 304.231.0797

Ihlenfeld’s practice focuses on health care litigation and compliance, along with health care fraud defense. He provides practical counsel and represents health care providers and provider organizations at trial, on appeal and in administrative and regulatory disputes. Ihlenfeld advises health care industry clients regarding licensing board investigations, cyber security, compliance issues, and federal investigations, to include false claims act matters, Stark Act, Medicare and Medicaid audits, DEA investigations, grand jury investigations, OIG subpoenas, civil investigative demands, and subpoenas to testify or produce documents.

Ihlenfeld proactively advocates for his clients’ best interests: avoiding charges or penalties if possible, settling if practical and litigating if required. He represents clients in proceedings initiated by a variety of agencies, and works with them on voluntary disclosure decisions and developing compliance programs to prevent issues from arising with law enforcement agencies. Clients include physicians, physician groups, hospital organizations, nurses, medical assistants, pharmacists, psychiatrists, psychologists, local and regional hospitals, national hospital systems, and medical schools.

In addition to his work in the health care arena, Ihlenfeld regularly handles complex civil litigation, internal investigations, and white collar criminal defense on behalf of corporate and individual clients in both state and federal court.

Ihlenfeld served with distinction as the presidentially-appointed United States Attorney for the Northern District of West Virginia from 2010 until 2016. While U.S. Attorney, he helped to investigate British banking giant HSBC for its failure to identify money laundering transactions related to Mexican drug trafficking as well as its hiding of transfers made for clients in foreign countries subject to U.S. sanctions. As a result of the prosecution, HSBC paid $1.92 billion in fines and was forced to change its internal operating procedures to come into compliance with anti-money laundering laws.

While serving as the top federal prosecutor in his district, Ihlenfeld placed special emphasis on the pursuit of white collar criminals and created a financial crimes initiative and a health care fraud working group in order to proactively identify federal criminal violations. He prosecuted cases involving health care fraud, financial fraud, tax evasion, money laundering, extortion and other crimes, and led successful investigations against pharmaceutical companies that filled suspicious orders for prescription pills.

Ihlenfeld represented the Department of Justice in the federal government’s effort to reduce the flow of illicit drugs coming into the United States, served as Vice-Chairman of the Appalachia HIDTA Executive Board, and received national recognition for his efforts to combat the country’s drug epidemic. In 2017, Ihlenfeld received the Outstanding Service in Law Enforcement Award from the FBI Citizens Academy Alumni Association for his distinguished record of law enforcement service.

Bar Admissions

West Virginia

Government Experience

U.S. Attorney, Northern District of West Virginia, 2010-2016
Brooke County Prosecuting Attorney’s Office, 2007-2010
Ohio County Prosecuting Attorney’s Office, 1997-2007

Court Admissions

U.S. Court of Appeals for the Fourth Circuit
U.S. District Court for the Northern District of West Virginia
U.S. District Court for the Southern District of West Virginia
U.S. District Court for the Northern District of Ohio
U.S. District Court for the Southern District of Ohio


  • “Medical Ethics and the Law: Poor prescribing practices help fuel West Virginia’s drug epidemic”, The West Virginia Lawyer, April-June 2015
  • “The right prescription for West Virginia: Reducing the supply of painkillers to ease the drug epidemic”, Wheeling Intelligencer/Clarksburg Exponent-Telegram/Martinsburg Journal, March 13, 2016
  • “Death Results Prosecutions Remain Effective Tool Post-Burrage”, United States Attorneys’ Bulletin, Volume 64, Number 5, September 2016
  • “Focus on Fentanyl: Awareness week shines light on emerging threat”, Wheeling Intelligencer/Clarksburg Exponent-Telegram/Martinsburg Journal, September 18, 2016
  • “Cybersecurity: Why It’s More Vital Than Ever”, West Virginia Banker, Summer 2017


  • Member of faculty for Violent Crime Summit at National Advocacy Center, Columbia, SC, February 2016
  • Presentation at United States Attorney’s National Conference on use of technology to combat crime, Department of Justice, Washington, D.C., March 2016
  • Presentation at Heroin Response Strategy Symposium, Towson University, Towson, MD, June 2016
  • Presentation to Global Advisory Committee to the United States Attorney General on use of technology to combat crime, Washington, D.C., December 2016
  • Presentation to W.Va. House of Delegates Substance Committee on Prevention and Treatment of Substance Abuse on opioid threat and response strategy, West Virginia State Capitol, Charleston, WV, February 2017
  • Presentation of “Cybersecurity for Lawyers: How to Meet and Exceed Your Ethical Obligations”, WVU College of Law Cyber & Technology CLE, Morgantown, WV, October, 2017
  • Presentation of “Cybersecurity in West Virginia and Beyond: Best Practice to Prevent Attacks and Respond to Intrusions” to the State Auditor’s Annual Seminar for Chapter 30 Licensing Boards, Charleston, WV, November, 2017